ENTITY
Sino Biopharmaceutical

Sino Biopharmaceutical (1177 HK)

191
Analysis
Health CareHong Kong
Sino Biopharmaceutical Limited, through its subsidiaries, researches, develops, produces, and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis.
more
09 Oct 2019 09:45

Innovent Biologics - Promising Phase I Results for Lung Cancer

In the recent 2019 World Conference on Lung Cancer held in Spain, Innovent Biologics reported preliminary results from a Phase I clinical trial on...

Logo
435 Views
Share
28 Sep 2019 10:37

HK Short Interest - Big Covering in Financials

We analyse the latest SFC data released Friday evening on short position reporting in Hong Kong for the week ended 20 September. Total short...

Logo
515 Views
Share
23 Sep 2019 10:59

HK Connect Ideas: First Weekly Outflows in 19 Weeks, SMIC, Auto Sector (2019-09-20)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
374 Views
Share
14 Sep 2019 11:52

HK Short Interest - Diverging Healthcare

We analyse the latest SFC data released Friday evening on short position reporting in Hong Kong for the week ended 6 September.Total short notional...

Logo
409 Views
Share
22 Jul 2019 11:39

HK Connect Ideas: Ten Weeks of Inflows, Sino Biopharm, Anta, Maoyan, H&H (2019-07-19)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
386 Views
Share
x